Luis I Ruffolo

7PUBLICATIONS

25CO-AUTHORS

Molecular targetsCancer geneticsForensic epidemiologyHaematological tumours

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Aug 05, 2024

Pan-lysyl oxidase inhibition disrupts fibroinflammatory tumor stroma, rendering cholangiocarcinoma susceptible to chemotherapy.

Paul R Burchard, Luis I Ruffolo, Nicholas A Ullman

|Feb 28, 2024

Smad4 restricts injury-provoked biliary proliferation and carcinogenesis.

William B Alexander, Wenjia Wang, Margaret A Hill

|Apr 25, 2022

What is the optimal prophylaxis against postoperative deep vein thrombosis in the living donor to avoid complications and enhance recovery? - A systematic review of the literature and expert panel recommendations.

Luis I Ruffolo, Mark Levstik, Jen Boehly

|Aug 20, 2021

GM-CSF drives myelopoiesis, recruitment and polarisation of tumour-associated macrophages in cholangiocarcinoma and systemic blockade facilitates antitumour immunity.

Luis I Ruffolo, Katherine M Jackson, Peyton C Kuhlers

Pageof 2

Frequent Collaborators

3 joint publications

Roberto Hernandez-Alejandro

2 joint publications

Aram F Hezel

2 joint publications

Mariana Chávez-Villa

2 joint publications

Pål-Dag Line

2 joint publications

Svein Dueland

2 joint publications

Matthew M Byrne

1 joint publications

Gregory B Lesinski

1 joint publications

William B Alexander

1 joint publications

Wenjia Wang

1 joint publications

Margaret A Hill

Frequent Collaborators

3 joint publications

Roberto Hernandez-Alejandro

2 joint publications

Aram F Hezel

2 joint publications

Mariana Chávez-Villa

2 joint publications

Pål-Dag Line